ROBERT RUNK: Open Payments
NPI 1093791584 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 7 payments from 6 companies in 2025. Trend: 2023 $490 · 2024 $14 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $231 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| INOGEN, INC. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: BREZTRI, VOQUEZNA, AIRSUPRA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, XIFAXAN, CAPLYTA, GATTEX.
Industry payments across FL — which companies pay providers there.
